{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:36:38Z","timestamp":1768340198261,"version":"3.49.0"},"reference-count":142,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018YFA0107900"],"award-info":[{"award-number":["2018YFA0107900"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771491"],"award-info":[{"award-number":["31771491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2019CXJQ01"],"award-info":[{"award-number":["2019CXJQ01"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2019.00209","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T04:17:39Z","timestamp":1565151459000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Entanglement of CCR5 and Alzheimer\u2019s Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Tianwen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"E865","DOI":"10.1208\/aapsj070484","article-title":"Viewing chemokines as a third major system of communication in the brain.","volume":"7","author":"Adler","year":"2005","journal-title":"AAPS J."},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0707199","article-title":"Guide to receptors and channels (GRAC).","author":"Alexander","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0049-7","article-title":"CXCR4 involvement in neurodegenerative diseases.","volume":"8","author":"Andreassen","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1074\/jbc.M112.384693","article-title":"Identification of the low density lipoprotein (LDL) receptor-related protein-1 interactome in central nervous system myelin suggests a role in the clearance of necrotic cell debris.","volume":"288","author":"Anthony","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/glia.21035","article-title":"Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.","volume":"58","author":"Avdoshina","year":"2010","journal-title":"Glia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1523\/jneurosci.23-21-07922.2003","article-title":"Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.","volume":"23","author":"Babcock Alicia","year":"2003","journal-title":"J. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/35055057","article-title":"RANTES promotes growth and survival of human first-trimester forebrain astrocytes.","volume":"3","author":"Bakhiet","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1196\/annals.1386.012","article-title":"Association between the polymorphism of CCR5 and Alzheimer\u2019s disease: results of a study performed on male and female patients from northern Italy.","volume":"1089","author":"Balistreri","year":"2006","journal-title":"Ann. N. Y. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/epi.12042","article-title":"Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins.","volume":"54","author":"Bien Christian","year":"2013","journal-title":"Epilepsia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13550280902913628","article-title":"Morphine enhances Tat-induced activation in murine microglia.","volume":"15","author":"Bokhari","year":"2009","journal-title":"J. Neurovirol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0165-5728(97)00054-4","article-title":"Activation of nuclear factor-kappa B by beta-amyloid peptides and interferon-gamma in murine microglia.","volume":"77","author":"Bonaiuto","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/j.jmb.2018.06.027","article-title":"CCR5 revisited: how mechanisms of HIV entry govern AIDS pathogenesis.","volume":"430","author":"Brelot","year":"2018","journal-title":"J. Mol. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/elife.20985","article-title":"CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory.","volume":"5","author":"Cai","year":"2016","journal-title":"Elife"},{"key":"B14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugalcdep.2006.09.010","article-title":"Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats.","volume":"88","author":"Chen","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"B16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nbd.2012.08.001","article-title":"Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.","volume":"49","author":"Choi","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/COH.0b013e328356e933","article-title":"Clinical studies with chemokine receptor-5 (CCR5)-inhibitors.","volume":"7","author":"Christoph","year":"2012","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0343-2","article-title":"LRP1 expression in microglia is protective during CNS autoimmunity.","volume":"4","author":"Chuang","year":"2016","journal-title":"Acta Neuropathol Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neulet.2004.05.058","article-title":"The chemokine receptor CCR5-\u039432 gene mutation is not protective against Alzheimer\u2019s disease.","volume":"366","author":"Combarros","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.10.2909","article-title":"HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling.","volume":"98","author":"Corno","year":"2001","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneuroim.2006.01.005","article-title":"Microglial expression of chemokine receptor CCR5 during rat forebrain development and after perinatal hypoxia-ischemia.","volume":"173","author":"Cowell","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-179","article-title":"Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study.","volume":"9","author":"Cribbs","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.tips.2017.07.005","article-title":"Early and late CNS inflammation in Alzheimer\u2019s disease: two extremes of a continuum?","volume":"38","author":"Cuello","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0366-9","article-title":"Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.","volume":"12","author":"Dagher","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1158\/0008-5472.CAN-14-0612","article-title":"CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.","volume":"74","author":"Daniela","year":"2014","journal-title":"Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.femsle.2004.09.040","article-title":"HIV and the CCR5-Delta32 resistance allele.","volume":"241","author":"De","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pneurobio.2016.01.002","article-title":"Positive modulators of the \u03b17 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer\u2019s disease.","volume":"144","author":"Echeverria","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nm1210-1369","article-title":"Neurodegeneration and the neuroimmune system.","volume":"16","author":"El","year":"2010","journal-title":"Nat. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1182\/blood-2002-05-1493","article-title":"CCR5 deficiency decreases susceptibility to experimental cerebral malaria.","volume":"101","author":"Elodie","year":"2003","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.bmcl.2007.12.058","article-title":"Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists.","volume":"18","author":"Ernst","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S2213-8587(13)70048-2","article-title":"Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study.","volume":"1","author":"Exalto","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1073\/pnas.1604032113","article-title":"IL-33 ameliorates Alzheimer\u2019s disease-like pathology and cognitive decline.","volume":"113","author":"Fu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nn.4597","article-title":"Transcriptomic analysis of purified human cortical microglia reveals age-associated changes.","volume":"20","author":"Galatro","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jns.2004.07.005","article-title":"CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer\u2019s disease.","volume":"225","author":"Galimberti","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation.","volume":"360","author":"Gero","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/COH.0b013e328324bbec","article-title":"The biology of CCR5 and CXCR4.","volume":"4","author":"Ghalib","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1471-4159.2004.02800.x","article-title":"Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor.","volume":"91","author":"Giri","year":"2010","journal-title":"J. Neurochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"C264","DOI":"10.1111\/j.1471-4159.2004.02800.x","article-title":"Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1.","volume":"289","author":"Giri","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/jvi.77.1.191-198.2003","article-title":"Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.","volume":"77","author":"Glass William","year":"2003","journal-title":"J. Virol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066664","article-title":"Enhanced chemokine receptor expression on leukocytes of patients with Alzheimer\u2019s Disease.","volume":"8","author":"Goldeck","year":"2013","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.","volume":"71","author":"Gottesman Rebecca","year":"2014","journal-title":"JAMA Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nn.2432","article-title":"Formation and maintenance of Alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia.","volume":"16","author":"Grathwohl","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-5","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity.","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease.","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1086\/518797","article-title":"Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1\u2013infected, treatment-experienced patients: AIDS clinical trials group 5211.","volume":"196","author":"Gulick","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3233\/JAD-160524","article-title":"A Common variant of IL-6R is associated with elevated IL-6 pathway activity in Alzheimer\u2019s Disease brains.","volume":"56","author":"Haddick","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcyt.2017.05.013","article-title":"CCR5-edited gene therapies for HIV cure: closing the door to viral entry.","volume":"19","author":"Haworth","year":"2017","journal-title":"Cytotherapy"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.yexcr.2009.06.017","article-title":"Chemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation.","volume":"315","author":"Hee","year":"2009","journal-title":"Exp. Cell Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease.","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice.","volume":"493","author":"Heneka Michael","year":"2013","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease.","volume":"16","author":"Heppner Frank","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","article-title":"TREM2 and the neuroimmunology of Alzheimer\u2019s disease.","volume":"88","author":"Hickman Suzanne","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0952-7915(01)00308-9","article-title":"The role of chemokines in linking innate and adaptive immunity.","volume":"14","author":"Hogaboam","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants in ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease.","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuropharm.2018.01.040","article-title":"Novel dual GLP-1\/GIP receptor agonists show neuroprotective effects in Alzheimer\u2019s and Parkinson\u2019s disease models.","volume":"136","author":"H\u00f6lscher","year":"2018","journal-title":"Neuropharmacology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neulet.2004.08.016","article-title":"Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer\u2019s and Parkinson\u2019s disease.","volume":"370","author":"Huerta","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"11984","DOI":"10.18632\/oncotarget.7453","article-title":"CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function.","volume":"7","author":"Hwang","year":"2016","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1021\/jm051034q","article-title":"Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent anti-HIV-1 activity.","volume":"49","author":"Imamura","year":"2006","journal-title":"J. Med. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/NEN.0000000000000176","article-title":"Neuroinflammatory signals in Alzheimer disease and APP\/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.","volume":"74","author":"Irene","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B61","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease.","volume":"41","author":"Jean-Charles","year":"2009","journal-title":"Nat. Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"9542","DOI":"10.1074\/jbc.M114.596098","article-title":"Biased signaling at chemokine receptors.","volume":"290","author":"Jenny","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1158\/0008-5472.CAN-17-5","article-title":"CCR5 governs DNA damage repair and breast cancer stem cell expansion.","volume":"78","author":"Jiao","year":"2018","journal-title":"Cancer Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1088469","article-title":"Immunotherapeutic approaches to Alzheimer\u2019s disease.","volume":"302","author":"Josef Karkos","year":"2003","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic Brain injury.","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/157016206777709384","article-title":"Mechanisms of neuronal injury and death in HIV-1 associated dementia.","volume":"4","author":"Kaul","year":"2006","journal-title":"Curr. HIV Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1056\/nejme1400593","article-title":"Engineering cellular resistance to HIV.","volume":"370","author":"Kay","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/713831547","article-title":"The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons.","volume":"9","author":"Khan","year":"2003","journal-title":"J. Neurovirol."},{"key":"B69","first-page":"937","article-title":"CCR2-64i and CCR5 \u039432 polymorphisms in patients with late-onset Alzheimer\u2019s disease; a study from Iran (CCR2-64i and CCr5 \u039432 polymorphisms in Alzheimer\u2019s disease).","volume":"15","author":"Khorshid","year":"2012","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm1210-1369","article-title":"Neurodegeneration and the neuroimmune system.","volume":"16","author":"Khoury","year":"2010","journal-title":"Nat. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/brain\/awu041","article-title":"Cardiovascular and cognitive fitness at age 18 and risk of early-onset dementia.","volume":"137","author":"Kuhn","year":"2014","journal-title":"Brain"},{"key":"B72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1471-4159.2010.06744.x","article-title":"beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 tat: effects on microglial migration.","volume":"114","author":"Kyung","year":"2010","journal-title":"J. Neurochem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry.","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/s0149-2918(08)80048-3","article-title":"Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection.","volume":"30","author":"Lieberman-Blum","year":"2008","journal-title":"Clin. Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3390\/molecules13102426","article-title":"Discovery of a novel CCR5 antagonist lead compound through fragment assembly.","volume":"13","author":"Liu","year":"2008","journal-title":"Molecules"},{"key":"B76","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/84205","article-title":"Chemokines as regulators of T cell differentiation.","volume":"2","author":"Luther","year":"2001","journal-title":"Nat. Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.neurobiolaging.2006.02.013","article-title":"Peripheral T cells overexpress MIP-1\u03b1 to enhance its transendothelial migration in Alzheimer\u2019s disease.","volume":"28","author":"Man","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"B78","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.","volume":"85","author":"Marie-Victoire","year":"2015","journal-title":"Neuron"},{"key":"B79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nn.2511","article-title":"Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer\u2019s disease.","volume":"13","author":"Martin","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.248","article-title":"CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.","volume":"12","author":"Martin-Blondel","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease.","volume":"41","author":"McGuinness","year":"2009","journal-title":"Nat. Genet."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.ajpath.2013.01.051","article-title":"Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice.","volume":"182","author":"Medeiros","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B83","first-page":"9363","article-title":"Chemokine receptor antagonists.","volume":"55","author":"Meyer","year":"2013","journal-title":"J. Med. Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.yexcr.2009.06.017","article-title":"Chemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation.","volume":"315","author":"Mi","year":"2009","journal-title":"Exp. Cell Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/wco.0b013e32832a323d","article-title":"Advances in the management of cerebral malaria in adults.","volume":"22","author":"Mishra Saroj","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1128\/MCB.00349-14","article-title":"Therapeutic potential of nuclear receptor agonists in Alzheimer\u2019s disease.","volume":"58","author":"Moutinho","year":"2017","journal-title":"J. Lipid Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","article-title":"High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease.","volume":"48","author":"Mrdjen","year":"2018","journal-title":"Immunity"},{"key":"B88","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.bcp.2006.06.001","article-title":"Diverse signalling by different chemokines through the chemokine receptor CCR5.","volume":"72","author":"Mueller","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.febslet.2004.04.100","article-title":"CCL3, acting via the chemokine receptor CCR5, leads to independent activation of janus kinase 2 (JAK2) and G i proteins.","volume":"570","author":"Mueller","year":"2004","journal-title":"FEBS Lett."},{"key":"B90","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/84214","article-title":"Viral exploitation and subversion of the immune system through chemokine mimicry.","volume":"2","author":"Murphy","year":"2001","journal-title":"Nat. Immunol."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1313-13","article-title":"Inflammation: the link between comorbidities, genetics, and Alzheimer\u2019s disease.","volume":"15","author":"Newcombe","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"B92","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.161.7.3330","article-title":"Roles of chemokines and receptor polarization in NK-target cell interactions.","volume":"161","author":"Nieto","year":"1998","journal-title":"J. Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer\u2019s disease: an analysis of population-based data.","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7150\/ijbs.26703","article-title":"Changes in chemokines and chemokine receptors expression in a mouse model of Alzheimer\u2019s Disease.","volume":"15","author":"Obrador","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/14656566.2018.1543403","article-title":"Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults.","volume":"20","author":"Ogawa","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuroscience.2018.02.012","article-title":"Inflammation as a possible link between dyslipidemia and Alzheimer\u2019s Disease.","volume":"376","author":"Oliveira","year":"2018","journal-title":"Neuroscience"},{"key":"B97","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","article-title":"Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology.","volume":"139","author":"Olmos-Alonso","year":"2016","journal-title":"Brain"},{"key":"B98","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.neulet.2004.05.058","article-title":"The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer\u2019s disease.","volume":"366","author":"Onofre","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cellsig.2004.04.007","article-title":"Chemokine receptor CCR5: insights into structure, function, and regulation.","volume":"16","author":"Oppermann","year":"2004","journal-title":"Cell. Signal."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.2353\/ajpath.2009.081113","article-title":"Role of the macrophage inflammatory protein-1alpha\/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide.","volume":"175","author":"Passos","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B101","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors.","volume":"3","author":"Pierce Kristen","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"19495","DOI":"10.1074\/jbc.270.33.19495","article-title":"Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line.","volume":"270","author":"Power","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B103","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration.","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"B104","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/M14-0737","article-title":"Diabetes in midlife and cognitive change over 20 years: a cohort study.","volume":"161","author":"Rawlings Andreea","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/jad-2008-14203","article-title":"Peripheral chemokine receptors, their ligands, cytokines and Alzheimer\u2019s disease.","volume":"14","author":"Reale","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bbmt.2018.09.034","article-title":"Extended CCR5 blockade for graft-versus-host disease Prophylaxis improves outcomes of reduced intensity unrelated donor hematopoietic cell transplantation: a Phase II clinical trial.","volume":"25","author":"Reshef","year":"2019","journal-title":"Biol. Blood Marrow Transplant"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5 32\/32 stem cell transplantation.","volume":"117","author":"Rieger","year":"2010","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/j.neurobiolaging.2015.02.016","article-title":"Age- and location-related changes in microglial function.","volume":"36","author":"Ritzel","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B109","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.1523\/jneurosci.5047-06.2007","article-title":"Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer\u2019s disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein.","volume":"27","author":"Rodrigo","year":"2007","journal-title":"J. Neurosci"},{"key":"B110","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuroscience.2005.04.029","article-title":"Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer\u2019s disease.","volume":"134","author":"Rosi","year":"2005","journal-title":"Neuroscience"},{"key":"B111","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1570162033352066","article-title":"Update on D-Ala-Peptide T-Amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors.","volume":"1","author":"Ruff","year":"2003","journal-title":"Curr. HIV Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10571-015-0327-y","article-title":"Evidence to consider angiotensin II receptor blockers for the treatment of early Alzheimer\u2019s Disease.","volume":"36","author":"Saavedra","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neulet.2004.08.016","article-title":"Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer\u2019s and Parkinson\u2019s disease.","volume":"370","author":"Salvador","year":"2004","journal-title":"Neurosci. Lett."},{"key":"B114","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00401-016-1630-5","article-title":"Soluble phospho-tau from Alzheimer\u2019s disease hippocampus drives microglial degeneration.","volume":"132","author":"Sanchez-Mejias","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418791107","article-title":"Can inflammation be resolved in Alzheimer\u2019s disease?","volume":"11","author":"Schultzberg","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B116","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/glia.20338","article-title":"Minocycline affects microglia activation, A\u03b2 deposition, and behavior in APP-tg mice.","volume":"53","author":"Seabrook","year":"2010","journal-title":"Glia"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4049\/jimmunol.1101121","article-title":"TLR2 is a primary receptor for Alzheimer\u2019s amyloid \u03b2 peptide to trigger neuroinflammatory activation.","volume":"188","author":"Shirong","year":"2012","journal-title":"J. Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnen\/59.5.339","article-title":"Expression of the \u03b2-chemokines RANTES and MIP-1\u03b2 by human brain microvessel endothelial cells in primary culture.","volume":"59","author":"Shukaliak","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1310\/hct1103-125","article-title":"Efficacy and safety of maraviroc versus efavirenz, both with zidovudine\/lamivudine: 96-week results from the merit study.","volume":"11","author":"Sierra-Madero","year":"2010","journal-title":"HIV Clin. Trials"},{"key":"B120","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking A\u03b2 and Tau in late-onset Alzheimer\u2019s Disease: a dual pathway hypothesis.","volume":"60","author":"Small","year":"2008","journal-title":"Neuron"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.003","article-title":"Inflammation in Alzheimer\u2019s disease: lessons learned from microglia-depletion models.","volume":"61","author":"Spangenberg","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.003","article-title":"Inflammation in Alzheimer\u2019s Disease: lessons learned from microglia-depletion models.","volume":"61","author":"Spangenberg","year":"2018","journal-title":"Brain Behav Immun."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","article-title":"Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology.","volume":"139","author":"Spangenberg","year":"2016","journal-title":"Brain"},{"key":"B124","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/jci5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.","volume":"103","author":"SRensen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10319","article-title":"Dystrophic microglia in the aging human brain.","volume":"45","author":"Streit Wolfgang","year":"2010","journal-title":"Glia"},{"key":"B126","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/jm100978n","article-title":"An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N -{(1 S)-1-(3-fluorophenyl)-3-[(3- endo)-3-(5-isobutyryl-2- methyl-4,5,6,7-tetrahydro-1 H -imidazo[4,5- c]pyridin-1-yl)-8-azabicyclo[3.2.1] oct-8-yl]propyl}acetamide (PF-232798).","volume":"54","author":"Stupple","year":"2011","journal-title":"J. Med. Chem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/NEN.0b013e318197eca7","article-title":"Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis.","volume":"68","author":"Subileau","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"35039","DOI":"10.1074\/jbc.M113.479113","article-title":"Biased agonism as a mechanism for differential signaling by chemokine receptors.","volume":"288","author":"Sudarshan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B129","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/13543784.2018.1442436","article-title":"Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis.","volume":"27","author":"Tacke","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/s0002-9440(10)63017-9","article-title":"CCR1+\/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.","volume":"159","author":"Trebst","year":"2001","journal-title":"Am. J. Pathol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1586\/eri.12.114","article-title":"The MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients.","volume":"10","author":"Van Lelyveld","year":"2012","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B132","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s1474-4422(13)70260-6","article-title":"Rasmussen\u2019s encephalitis: clinical features, pathobiology, and treatment advances.","volume":"13","author":"Varadkar","year":"2014","journal-title":"Lancet Neurol."},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3917","article-title":"CCR5 antagonist blocks metastasis of basal breast cancer cells.","volume":"72","author":"Velasco-Vel\u00e1zquez","year":"2012","journal-title":"Cancer Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"12231","DOI":"10.1523\/JNEUROSCI.3212-08.2008","article-title":"Rantes modulates the release of glutamate in human neocortex.","volume":"28","author":"Veronica","year":"2008","journal-title":"J. Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","article-title":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function.","volume":"477","author":"Villeda Saul","year":"2011","journal-title":"Nature"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/brain\/awn331","article-title":"Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer\u2019s disease.","volume":"132","author":"Vincent","year":"2009","journal-title":"Brain"},{"key":"B137","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/s0197-4580(01)00306-2","article-title":"Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia.","volume":"22","author":"Walker","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"B138","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0002-9440(10)65542-3","article-title":"Immunohistochemical study of the \u03b2-Chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer\u2019s disease brains.","volume":"153","author":"Xia","year":"1998","journal-title":"Am. J. Pathol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","article-title":"Rage and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease.","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"B140","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nlm.2009.04.003","article-title":"CCR5 deficiency induces astrocyte activation, A\u03b2 deposit and impaired memory function.","volume":"92","author":"Yong","year":"2009","journal-title":"Neurobiol. Learn. Mem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/liv.13698","article-title":"Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.","volume":"38","author":"Yu","year":"2018","journal-title":"Liver Int."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2019.00209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T21:57:25Z","timestamp":1695074245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnagi.2019.00209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":142,"alternative-id":["10.3389\/fnagi.2019.00209"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2019.00209","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"article-number":"209"}}